STOCK TITAN

[6-K] NewGenIvf Group Ltd Current Report (Foreign Issuer)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

NewGenIVF Group Limited announced a major capitalization milestone tied to its strategic pivot toward artificial intelligence and digital assets. The company issued 3,666,667 new shares, bringing total outstanding shares to 10,073,535 after transactions linked to acquiring a 10% equity interest in K25.ai.

NewGenIVF reports a market capitalization of US$7,631,710 as of June 18, 2026, compared with an approximate net asset value of US$25.98 million as of December 31, 2025. Management highlights this gap while noting a US$10 million investment in K25.ai and a digital assets treasury strategy as part of a broader shift toward AI, digital engagement, and prediction markets in APAC.

The company believes this capitalization supports strategic investments, commercial partnerships, and helps it be well-positioned to meet Nasdaq’s proposed US$5 million Market Value of Listed Securities threshold, reinforcing confidence in maintaining its listing as it pursues growth initiatives.

Positive

  • None.

Negative

  • None.

Insights

NewGenIVF trades dilution for capital and a higher-risk AI pivot.

NewGenIVF has materially expanded its equity base by issuing 3,666,667 new shares, lifting outstanding shares to 10,073,535. Alongside this, it committed US$10 million for a 10% stake in K25.ai and is adopting a digital assets treasury strategy.

Management frames the resulting US$7.63 million market capitalization as a discount to a US$25.98 million net asset value as of December 31, 2025. The company also emphasizes that this capitalization level supports its position relative to Nasdaq’s proposed US$5 million MVLS threshold, which is important for listing continuity.

The filing also outlines substantial risks: share dilution, volatility around digital assets, business transformation across multiple new lines, and the possibility that the K25.ai investment could be impaired. Subsequent filings may clarify how these new businesses contribute to revenue and whether the valuation gap to net asset value narrows.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

Commission File Number: 001-42004

 

NEWGENIVF GROUP LIMITED

 

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 

 

EXPLANATORY NOTE

 

On June 22, 2026, the Company issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

1

 

 

EXHIBIT INDEX

 

Exhibit   Description
99.1   Press release

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: June 22, 2026

 

  NewGenIvf Group Limited
     
  By: /s/ Wing Fung Alfred Siu
  Name:  Wing Fung Alfred Siu
  Title: Chairman of the Board and Director

 

3

 

Exhibit 99.1

 

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

 

Strong Capitalization Foundation Supports Strategic Growth and Market Stability

 

BANGKOK – June 22, 2026 – NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”) today announced that NewGen’s total outstanding shares now stand at 10,073,535 following share issuances in connection with its strategic share purchase agreements to acquire a 10% equity interest in K25.ai. The Company’s market capitalization reached US$7,631,710 on June 18, 2026, providing a solid foundation for future growth. Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 million investment in K25.ai.

 

This capital strength follows the Company’s recently announced strategic direction shift, including the definitive investment agreement with K25.ai, an AI-powered live-streaming prediction market platform, and the adoption of a digital assets treasury strategy. The K25.ai transaction has furthered NewGen’s deliberate pivot toward high-growth opportunities at the intersection of artificial intelligence, digital engagement, and emerging information markets across permitted APAC jurisdictions.

 

As the Company continues to execute on this new trajectory, a solid capitalization base provides the financial foundation necessary to support strategic investments, pursue commercial partnerships, and maximize the Company’s ability to generate value for its shareholders.

 

With this increased capitalization, NewGen believes that it is now well-positioned to meet the Nasdaq’s proposed minimum Market Value of Listed Securities (MVLS) threshold of US$5 million, reinforcing the Company’s confidence in its continued compliance and its ability to maintain a stable public market presence as it advances its strategic growth initiatives.

 

“Exceeding US$7.6 million in share capitalization with over 10 million shares outstanding is a significant milestone for NewGen,” said Mr. Alfred Siu Wing Fung, Founder, Chairman and Chief Executive Officer of NewGen. “This valuation remains well below the Company’s net asset value of approximately US$25.98 million as of December 31, 2025 — prior to the addition of the US$10 million K25.ai investment — highlighting the meaningful upside potential as we continue executing our strategy. Our recent agreement with K25.ai reflects the new direction we are pursuing, focused on AI, digital platforms, and high-growth categories in APAC. A strong capital structure ensures we have the credibility and stability to execute that vision and provide the best value to our shareholders.”

 

Looking ahead, NewGen intends to further enhance its shareholder base through disciplined strategic investments and active recruitment of more medium-term investors who believe in the Company’s business model and investment strategies. By attracting like-minded, value-oriented shareholders, the Company aims to build a more stable and supportive ownership structure that aligns with its long-term growth objectives.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding: the Company’s market capitalization representing a discount to net asset value and the implied upside potential; the adoption and implementation of a digital assets treasury strategy; the Company’s strategic pivot toward opportunities in artificial intelligence, digital engagement, and prediction markets; the Company’s ability to use its capitalization to support strategic investments, pursue commercial partnerships, and generate value for shareholders; the Company’s confidence in meeting Nasdaq’s proposed minimum Market Value of Listed Securities threshold; and the Company’s intention to enhance its shareholder base.

 

 

 

These forward-looking statements are based on the Company’s current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: share dilution and capital markets issuance risk; Nasdaq listing and market capitalization compliance risk; share price volatility; risks relating to the Company’s digital asset treasury strategy, including price volatility, custody and cybersecurity risk, and evolving regulation of digital assets; business transformation and execution risk arising from the Company’s ongoing strategic pivot across multiple new business lines; the risk that the carrying value of the Company’s investment in K25.ai is not realized and may be impaired; and regulatory risk specific to prediction-market and information-market products. Additional risks are described in the Company’s Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.

 

All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements,, except as required by applicable securities laws.

 

About NewGen

 

NewGenIVF Group is a tech-forward, diversified growth company pursuing opportunities at the intersection of artificial intelligence, real estate development and reproductive health solutions. The Company operates through “NewGenDigital,” focused on AI, prediction markets and digital asset innovation (including its strategic investment in K25.ai); “NewGenProperty,” focused on real estate development projects in the UAE’s Ras Al Khaimah Emirate; and “NewGenSup,” focused on health and longevity products and solutions; and its legacy IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGenIVF’s website is not incorporated by reference into this press release and should not be considered part of this press release.

 

Contacts

 

NewGen Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email: NewgenivfIR@icrinc.com

 

Filing Exhibits & Attachments

1 document